Harbin Gloria Pharmaceuticals

SHE:002437 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.59 Billion CNY

Market Cap Rank

#7727 Global

#1359 in China

Share Price

CN¥3.40

Change (1 day)

+1.49%

52-Week Range

CN¥2.34 - CN¥4.04

All Time High

CN¥11.06

Harbin Gloria Pharmaceuticals - Asset Resilience Ratio

Latest as of September 2025: 12.90%

Harbin Gloria Pharmaceuticals (002437) has an Asset Resilience Ratio of 12.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥390.82 Million

Cash + Short-term Investments

Total Assets

CN¥3.03 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Harbin Gloria Pharmaceuticals's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Harbin Gloria Pharmaceuticals's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥390.82 Million	12.9%
Total Liquid Assets	CN¥390.82 Million	12.90%

Asset Resilience Insights

Moderate Liquidity: Harbin Gloria Pharmaceuticals has 12.90% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.